Publication | Open Access
Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
262
Citations
23
References
2022
Year
LSD produced long-lasting and notable reductions in anxiety and comorbid depression symptoms up to 16 weeks.
| Year | Citations | |
|---|---|---|
Page 1
Page 1